Leaflet DUOKOPT 20mg / 5mg / ml ophthalmic drops solution


Indicated for: glaucoma; ocular hypertension

Substance: dorzolamide (glaucoma agent)

ATC: S01ED51 (Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents)

Dorzolamidum is a medication used for the treatment of glaucoma and ocular hypertension. It is a carbonic anhydrase inhibitor that reduces the production of aqueous humor, thereby lowering intraocular pressure.

The medication is available as eye drops and is usually administered two or three times daily, according to the doctor's instructions. It is effective in preventing optic nerve damage and preserving vision.

Side effects may include burning or stinging sensation in the eyes, bitter taste, dry eyes, and, in rare cases, allergic reactions. Regular monitoring of intraocular pressure is essential.

Consult your doctor to discuss the benefits and risks of treatment with Dorzolamidum. Follow the administration instructions to ensure treatment effectiveness.

General data about DUOKOPT 20mg / 5mg / ml

  • Substance: dorzolamide
  • Date of last drug list: 01-07-2015
  • Commercial code: W61082001
  • Concentration: 20mg / 5mg / ml
  • Pharmaceutical form: ophthalmic drops solution
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: DELPHARM TOURS - FRANTA
  • Holder: LABORATOIRES THEA - FRANTA
  • Number: 12977/2020/01
  • Shelf life: 2 years-after packing for marketing;after the first opening-it is used immediately

Pharmaceutical forms available for dorzolamide

Concentrations available for dorzolamide

  • 20mg/5mg/ml
  • 20mg/ml

Combinations with other substances